期刊文献+

人端粒酶逆转录酶基因小片段干扰RNA慢病毒表达载体的构建及其在子宫颈癌caski细胞的表达 被引量:4

Construction of a plasmid expressing small hairpin RNA against human telomerase reverse transcriptase and functional analysis in the caski cervical cancer line
下载PDF
导出
摘要 目的构建及鉴定携带沉默人端粒酶逆转录酶基因(human telomerase reverse transcriptase,h TERT)慢病毒(lentivirus,LV)表达载体,并观察其在子宫颈癌caski细胞的表达情况。方法以Designer3.0(Genepharma)软件设计靶向h TERT基因特异性的小片段RNA(sh RNA)干扰序列,将h TERT-sh RNA基因片段插入重组慢病毒p GLV3/H1/GFP+Puro,构建慢病毒表达质粒LV3-sh RNA-h TERT,酶切、DNA测序验证h TERT片段准确性。LV3-sh RNA-h TERT与包装质粒共转染293T细胞,浓缩上清液并测定病毒滴度获得重组慢病毒后感染caski细胞。将细胞分为空白对照组(未感染病毒的caski细胞)、阴性对照组(感染空载病毒LV3-sh NC的caski细胞)和h TERT干扰组(感染携带LV3-shh TERT慢病毒的caski细胞)。绿色荧光蛋白(GFP)的表达判断转染结果并估计转染效率,流式细胞术仪检测病毒感染率,实时荧光定量PCR法(q RT-PCR)检测转染后基因h TERT m RNA的表达情况,CCK-8法检测caski细胞增殖情况。结果将目的序列成功连接到载体上,并经测序分析证实载体构建成功;成功包装成高滴度的慢病毒,且能有效感染子宫颈癌caski细胞。荧光定量PCR检测结果证实构建的h TERT-小片段干扰RNA慢病毒表达载体可显著抑制h TERT基因的表达。h TERT干扰组细胞增殖受抑制,生长速度较阴性对照组生长缓慢。结论成功构建了携带h TERT-sh RNA慢病毒表达载体LV3-sh RNA-h TERT,并稳定转染子宫颈癌caski细胞。该载体能够有效抑制h TERT的表达,使子宫颈癌caski细胞增殖缓慢,为进一步探讨h TERT基因在子宫颈癌的发病机制和体外基因干预治疗奠定基础。 Objective To construct a plasmid expressing a small hairpin RNA (shRNA) to knockdown expression of human telomerase reverse transcriptase (hTERT),and to observe its effects on hTERT expression in caski cervical cancer cells. Methods Designer 3.0 software (Genepharma) was used to design an shRNA targeting hTERT. The shRNA was cloned into the pGI,V3/Hi/GFP+Puro vector and confirmed by sequencing. Cells were divided into blank control group,negative control group and hTERT interference group. The resulting plasmid was transfected into easki cervical cancer cells and expression of the GFP reporter was analyzed. In addition,expression of chromosomal hTERT mRNA was quantified using RT-PCR. Cell proliferation in the presence and absence of shRNA was measured using the cck-8 assay. Results A plasmid expressing an shRNA targeting hTERT was constructed and used to generate recombinant lentivirus. Lentiviral infection of caski ceils led to lower expression of hTERT mRNA and slower cell proliferation than in controls. Conclusion A plasmid expressing shRNA targeting hTERT can effectively knockdown endogenous hTERT expression. This reagent may prove useful for understanding the role of telomerase in the pathogenesis of cervical cancer.
出处 《中国癌症防治杂志》 CAS 2014年第4期342-347,共6页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
基金 广西自然科学基金资助项目(2013GXNSFAAO19254)
关键词 子宫颈肿瘤 人端粒酶逆转录酶基因 慢病毒载体 小片段RNA CASKI细胞 Cervical neoplasm Human telomerase reverse transcriptase gene (hTERT) Lentivirus-based vectors Small hairpin RNA Caski cell
  • 相关文献

参考文献23

  • 1吴令英,安菊生.宫颈癌治疗中的几个特殊问题[J].中国癌症防治杂志,2012,4(1):5-8. 被引量:8
  • 2Corusi A,Skrgati L,Mahovli V,et al.Cervical cancer as a publichealth issue-what next?[j].Coll Antropol,2010,34( 1 ) : 301-307.
  • 3Howie HL, Katzenellenbogen RA, Galloway DA.Papilloma virus E6proteins[ j]. Virology,2009,384(2) : 324-334.
  • 4Wai LK.Telomeres.telomerase,and tumorigenesis-a review[j].MedCen Med,2004,6(3):19.
  • 5贾海英,张涛,唐智,王继群.siRNA抑制喉鳞状细胞癌Hep-2细胞生长的作用[J].临床耳鼻咽喉头颈外科杂志,2010,24(7):308-310. 被引量:3
  • 6Fire A,Xu S,Montgomery MK,et al.Potent and specific interferenceby double-stranded RNA in caenorhabditis elegans[j].Nature, 1988,391(6669):806-811.
  • 7Ui-Tei K’Naito Y,Takahashi F,et al.Guidelines for the selection ofhighly effective siRNA sequences for mammalian and chick RNA in-terference [J ].Nucleic Acids Res,2004,32(3) :936-948.
  • 8Kirkpatrick KL, Mokhel K.The significance of human telomerase reversetranscriptase (hTERT )in nancer[j].Eur J Surg Oncol,2001,27(8):754-760.
  • 9Wirth MG,Russell-Eggitt IM, Craig JE, et al.Aetiology of congenital and paediatric cataract in an Australian population [ J ].Br J Ophthalmol, 2002,86(7): 782- 786.
  • 10Reddy MAtFrancis PJ,Berry V,et al.Molecular genetic basis of in -herited cataract and associated phenotypes [ J ] .Surv Ophthalmol,2004,49?3):300-315.

二级参考文献20

  • 1李子庭,张志毅.子宫颈癌的变迁与治疗的策略[J].上海医学,2004,27(9):626-628. 被引量:5
  • 2邓继先,沈伟.用慢病毒载体制备转基因动物的研究进展[J].中国生物工程杂志,2004,24(9):16-20. 被引量:18
  • 3周健光,郑敏.TARC在某些皮肤疾病的研究进展[J].国外医学(皮肤性病学分册),2005,31(1):30-32. 被引量:2
  • 4赵金红,王健.趋化因子的研究进展[J].陕西医学杂志,2005,34(12):1542-1544. 被引量:16
  • 5张婵,邵艳军.基因治疗的病毒载体系统[J].生物技术,2007,17(1):90-93. 被引量:10
  • 6HUTVAGNER G, ZAMORE P D. RNAi : nature abhors a double-strand[J]. Curr Opin Genet Dev, 2002,12:225-32.
  • 7DZITOYEVA S,DIMITRIJEVIC N, MANEV H. Intra-abdominal injection of double-stranded RNA into anesthetized adult Drosophila triggers RNA interference in the central nervous system[J]. Mol Psychiatry, 2001,6: 665- 670.
  • 8TUSEHL T, ZAMORE P D, LEHMANN R, et al. Targeted mRNA degradation by double-stranded RNA in vitro[J]. Genes Dev, 1999,13 : 3191-3197.
  • 9陈雯 张桥 魏青 等.5-3叠氮脱氧胸腺核苷和硫代反义寡核苷酸抑制肿瘤细胞的生长以及端粒酶的活性.癌变.畸变.突变,1999,11(6):313-313.
  • 10KOLQUIST K A ,ELLISEN L W,COUNTER C M, et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues[J]. Nat Genet, 1998,19 : 182-186.

共引文献17

同被引文献27

  • 1Corusic A, Skrgatic AL, Mahovlic AV, et al. Cervical cancer as a public health issue-what next? [ J ]. Coil Antropol, 2010,34(1) :301 -307.
  • 2Akiyama BM, Stone MD. Structural biology:a solution to the telomerase puzzle[J]. Nature,2013,496(7 444) :177 -178.
  • 3Cantrell LA, Zhou C, Mendivil A, et al. Mefformin is a potent inhibitor of endometrial cancer cell proliferation-implica- tions for a novel treatment strategy [ J ]. Gynecol Oncol, 2010,116(1) :92 -98.
  • 4Scheffner M, Werness BA, Huibregtse JM, et al. The E6 onco- protein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 [ J ]. Cell, 1990, 63 ( 6 ) : 1 129-1 136.
  • 5Bak D. RNAi-RNA interference-an efficient way for silence [ J ]. Postepy Biochem,2003,49 (3) : 136 - 146.
  • 6Hannon GJ. RNA interference [ J]. Nature, 2002, 418 (6894) :244 -251.
  • 7Alisky JM, Davidson BL. Toward therapy using RNA inter- ference [ J ]. Am J Pharmaeogenomies ,2004,4 ( 1 ) :45 - 51.
  • 8Wyatt HD, West SC, Beattie TL. InTERTpreting telomerase structure and function [ J ]. Nucleic Acids Res, 2010, 38 (17) :5 609 -5 622.
  • 9Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions [ J ]. Nat Rev Drug Discov, 2006,5 (7) : 577 - 584.
  • 10Aubert G, Lansdorp PM. Telomeres and aging [ J ]. Physiol Rev,2008,88(2) :557 -579.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部